Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
5.65
-0.16 (-2.75%)
At close: Jun 26, 2026, 4:00 PM EDT
5.61
-0.04 (-0.71%)
After-hours: Jun 26, 2026, 7:59 PM EDT

Nuvation Bio Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Nuvation Bio stock has a consensus rating of "Strong Buy" and an average price target of $12.33. The average 1-year stock price forecast is 118.23% higher than the current stock price, while the lowest is $7.00 (+23.89%) and the highest is $20 (+253.98%).

Price Target: $12.33 (+118.23%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$7.00$12.33$12$20
Change+23.89%+118.23%+112.39%+253.98%
* Price targets were last updated on May 26, 2026.

Analyst Ratings

The average analyst rating for Nuvation Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy777777
Buy222222
Hold111111
Sell000000
Strong Sell000000
Total101010101010

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Truist Financial
Truist Financial
Buy
Maintains
n/a
BuyMaintainsn/an/aJun 10, 2026
TD Cowen
TD Cowen
Buy
Reiterates
n/a
BuyReiteratesn/an/aJun 1, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$17
BuyReiterates$17+200.88%May 26, 2026
B. Riley Securities
B. Riley Securities
Buy
Maintains
$12
BuyMaintains$12+112.39%May 21, 2026
Wedbush
Wedbush
Buy
Maintains
$11
BuyMaintains$11+94.69%May 5, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
202.59M
from 62.90M
Increased by 222.07%
Revenue Next Year
290.27M
from 202.59M
Increased by 43.28%
EPS This Year
-0.28
from -0.49
EPS Next Year
-0.06
from -0.28
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
---7.87M62.90M202.59M
Revenue Growth
----698.96%222.07%
Gross Profit
---795.00K53.60M184.71M
Gross Margin
---10.10%85.22%91.17%
Operating Income
-89.53M-119.73M-99.82M-167.56M-213.06M-127.51M
Net Income
-86.85M-104.20M-75.80M-567.94M-204.63M-116.79M
EPS
-----0.49-0.28
Free Cash Flow
-39.03M-62.44M-41.59M-52.19M-115.78M-87.92M
No. Analysts
-----10
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High215.5M
Avg202.6M
Low181.6M

Revenue Growth

Revenue Growth202620272028
High
242.6%
Avg
222.1%
Low
188.7%

EPS Forecast

EPS202620272028
High-0.28
Avg-0.28
Low-0.28

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-